Active Ingredient: OCTREOTIDE ACETATE
Proprietary Name: MYCAPSSA
Dosage Form; Route of Administration: CAPSULE, DELAYED RELEASE; ORAL
Strength: EQ 20MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N208232
Product Number: 001
Approval Date: Jun 26, 2020
Applicant Holder Full Name: CHIESI FARMACEUTICI SPA
Marketing Status:
Prescription
Patent and Exclusivity Information
